COBAS® TaqMan® CT Test, v2.0 

 
Registration Status

Canada-IVD
CE-IVD
Dual targeting – To Keep Up with the Unexpected
CT assay simultaneously detects two C. trachomatis (CT) independent DNA targets
This test incorporates a dual-target strategy – cryptic plasmid DNA and MOMP gene genomic DNA – to ensure accurate and reliable detection of Chlamydia, including the variant strain found in Sweden.
Features and Benefits
 
Features
  • Additional target on genome with MOMP and additional probe and primers
  • Stronger signal and superior sensitivity
  • Optimized thermal cycle parameters permit simultaneous detection of cryptic plasmid and genome targets
  • Reformulated control buffer
  • Detects the Swedish variant
Benefits
  • Identifies the recent mutation seen in Sweden – nvCT – and ensures that any future mutations will also be detected
  • Enables robust, reliable, and sensitive CT detection
  • Provides greater sensitivity for detection of wild-type Chlamydia by targeting the cryptic plasmid being present at 4-10 copies in each elementary body
  • Fully compatible with the COBAS® TaqMan® CT Test – Requires same collection media and same quantities of reagent and samples
Intended Use
 
This test is an in vitro nucleic acid amplification test for the qualitative detection of Chlamydia trachomatis DNA in female endocervical swab specimens or male and female urine. Specimens are processed using the AMPLICOR® CT/NG Specimen Preparation Kit for manual specimen preparation and the COBAS® TaqMan® 48 Analyzer for automated amplification and detection.
 
Not available in the United States
More Information
 
For regulatory reasons we are not able to provide further details on our products on this website, but more information may be available from our regional sales representatives.
 
 

 

Contact

Contact your local sales representative for detailed information, questions and ordering.

 

Browse Our Products

 

 Related Assays

 Related Instruments